Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Osteoarthritis
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden
Valgerdur Sigurdardottira Department of Rheumatology, Falun Hospital, Centre for Clinical Research, Dalarna, Uppsala University, Falun, Sweden
https://orcid.org/0000-0002-9907-4901View further author information
https://orcid.org/0000-0002-9907-4901View further author information, , , Tor Olofssonc Department of Rheumatology, Lund Universityhttps://orcid.org/0000-0002-9919-4487View further author information
https://orcid.org/0000-0002-9919-4487View further author information, Linnea Oldsbergd Quantify Research, Stockholm, Swedenhttps://orcid.org/0000-0002-6194-0982View further author information
https://orcid.org/0000-0002-6194-0982View further author information, Susannah Sadlere Cytel, London, England, United Kingdomhttps://orcid.org/0000-0001-5935-8507View further author information
https://orcid.org/0000-0001-5935-8507View further author information, Devian Parra-Padillaf Cytel, Rotterdam, Netherlandshttps://orcid.org/0000-0002-0781-8441View further author information
https://orcid.org/0000-0002-0781-8441View further author information, & Damon Willemsg UCB Pharma, Brussels, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0001-8263-4047View further author information
https://orcid.org/0000-0001-8263-4047View further author information show all